peopl
age
experi
viral
respiratori
tract
infect
year
young
children
elderli
immun
compromis
sever
afflict
epidemiolog
survey
diagnost
studi
identifi
common
agent
includ
respiratori
syncyti
viru
rsv
influenza
virus
flu
human
metapneumoviru
hmpv
rhinovirus
rv
parainfluenza
viru
piv
adenoviru
ad
human
coronaviru
hcov
common
virus
abil
infect
airway
epitheli
cell
coopt
host
cell
protein
facilit
infect
modul
innat
adapt
immun
respons
mediat
proinflammatori
respons
contribut
diseas
pathogenesi
despit
airway
constantli
challeng
airway
defens
mechan
gener
protect
diseas
minim
clinic
consequ
wellunderstood
airway
epitheli
cell
possess
innat
immun
function
control
infect
replic
recruit
activ
facilit
expans
adapt
immun
respons
facilit
clearanc
infect
epitheli
cell
respons
part
mediat
pattern
recognit
receptor
prr
tolllik
receptor
tlr
act
viral
sensor
infect
distribut
tlr
shown
depend
type
cell
local
shown
import
sens
rsv
infect
express
link
diseas
outcom
howev
virus
sens
via
prr
rna
virus
influenza
rsv
rapidli
detect
replic
intracellular
prr
rigi
virus
induc
activ
ifnpromot
via
rigi
signal
signal
role
antivir
respons
infect
rsv
interact
host
airway
epithelium
lead
induct
cytokin
chemokin
antivir
agent
respons
occur
earli
ie
express
viral
protein
exampl
express
cell
surfac
respiratori
epitheli
cell
respond
rsv
fusion
protein
signal
activ
nfkappa
b
via
trif
activ
cytokin
chemokin
ifn
express
result
cytokin
cascad
lead
proinflammatori
respons
must
neg
regul
primarili
suppressor
cytokin
signal
soc
protein
recent
novel
class
antivir
cytokin
discov
classifi
type
iii
ifn
ifn
lambda
potent
antivir
affect
rsv
influenza
viru
replic
featur
may
also
affect
influenza
reassort
suscept
cell
airway
epitheli
cell
import
recruit
activ
immun
cell
defens
viral
infect
cell
express
pattern
type
cytokin
chemokin
wide
rang
effect
innat
adapt
process
rsv
interfer
host
antivir
cytokin
respons
studi
shown
rsv
nonstructur
protein
antagon
ifn
respons
infect
epitheli
cell
affect
dendrit
cell
matur
rsv
g
protein
also
shown
affect
pattern
magnitud
cytokin
chemokin
express
lung
follow
infect
mice
well
traffick
immun
cell
recent
evid
indic
rsv
g
protein
govern
host
cell
respons
associ
microrna
mirna
express
mediat
central
conserv
region
g
protein
significantli
rsv
infect
human
alveolar
epitheli
cell
line
induc
five
mirna
repress
two
mirna
whose
target
includ
cellcycl
gene
chemokin
gene
modul
mirna
level
mirna
mimic
inhibitor
affect
rsv
replic
indic
rsv
modul
host
mirna
express
affect
outcom
antivir
host
respons
mediat
part
rsv
g
protein
express
numer
mous
human
studi
reveal
rsv
protein
modul
mani
aspect
immun
respons
infect
particularli
rsv
g
protein
primari
contributor
g
protein
immun
modul
diseas
pathogenesi
chemokin
mimicri
mediat
motif
central
conserv
region
g
protein
g
protein
bind
fractalkin
receptor
g
protein
interact
facilit
viru
infect
modul
leukocyt
chemotaxi
advers
affect
rsvspecif
cytotox
cell
respons
enhanc
diseas
pathogenesi
sever
studi
shown
antibodi
block
g
protein
interact
protect
g
proteinassoci
pulmonari
inflamm
diseas
outcom
neutral
protect
rsv
challeng
import
antirsv
g
protein
antibodi
respons
reveal
human
studi
show
antirsv
g
protein
antibodi
respons
recent
rsv
infect
vaccin
associ
inhibit
rsv
g
protein
interact
rsv
g
proteinmedi
leukocyt
chemotaxi
find
suggest
vaccin
strategi
target
antibodi
g
protein
could
efficaci
inde
shown
g
protein
vaccin
induc
antibodi
block
g
protein
interact
reduc
pulmonari
inflamm
viru
replic
mice
mice
immun
rsv
g
polypeptid
gener
antibodi
block
bind
rsv
nativ
g
protein
antibodi
effect
crossneutr
b
strain
rsv
current
diseas
intervent
strategi
rsv
limit
larg
ineffect
featur
true
influenza
well
protect
via
vaccin
unsuccess
rsv
complic
influenza
rapid
evolut
link
mutil
antigen
drift
reassort
antigen
shift
featur
mediat
drug
resist
thu
new
diseas
intervent
strategi
urgent
requir
import
first
step
increas
understand
virushost
interfac
studi
perform
har
power
rna
interfer
rnai
use
small
interf
rna
sirna
either
target
viru
gene
directli
silenc
host
gene
requir
viru
replic
control
rnai
use
provid
power
platformen
technolog
allow
identif
valid
virushost
interact
pathway
proand
antivir
gene
discov
rnai
screen
provid
opportun
transit
find
toward
translat
diseas
intervent
approach
creation
novel
therapeut
drug
reposit
creat
new
gener
vaccin
cell
line
capabl
increas
viral
product
airway
epithelium
central
role
defens
respiratori
viru
infect
express
antivir
immun
signal
mechan
contribut
viral
resist
clearanc
howev
respiratori
virus
evolv
strategi
subvert
defens
mechan
lead
cytopathogenesi
increas
inflammatori
respons
diseas
thorough
understand
mechan
virus
modifi
innat
adapt
immun
respons
need
develop
new
therapeut
approach
treat
prevent
respiratori
diseas
caus
import
human
viral
infect
mediat
rsv
influenza
virus
author
financi
conflict
interest
